With a 4.2% CAGR, the global pollen allergy market is expected to be valued US$ 5850.8 million in 2023. As a result of technological advances in healthcare, the market is expected to reach US$ 8828.6 million by 2033.
The rising number of people suffering from pollen-based allergies, such as hay fever, is driving market expansion. Furthermore, the global pollen allergy market is growing due to an increase in the number of sufferers, particularly children. Rapid urbanisation in emerging nations would be a major factor driving the growth of the pollen allergy market during the forecast period.
Request a report sample to gain comprehensive insights@ https://www.futuremarketinsights.com/reports/sample/rep-gb-16236
Increased greenhouse gas emissions may result in pollen-induced reparative sickness, slowing the expansion of the pollen allergy industry.
In terms of revenue share, corticosteroids dominated the pollen allergy market, and their use as a first-line treatment is expected to contribute to market expansion.
North America has dominated the global pollen allergy market due to the increasing prevalence of allergies and awareness of therapy. The pollen allergy market in Europe is expected to be the world’s second largest. Increasing disease awareness among people is another important factor that could boost market expansion in this region.
Key Takeaways from the Market Study
- The pollen allergy market was worth $5850.8 million in 2023.
- The pollen allergy industry is expected to increase at a 4.2% CAGR between 2023 and 2033.
- The pollen allergy market is expected to be worth US$ 8828.6 million by 2033.
- Corticosteroids dominated the pollen allergy market in 2023, accounting for 35.5% of total revenue.
- In terms of pollen allergies, China is expected to produce a CAGR of 3.8% by 2033.
“Technological advancement in healthcare and increase in the prevalence of allergic rhinitis and rise in the number of patients especially children suffering from pollen allergies expected to radically transform the pollen allergy market in the coming years,” comments an analyst at FMI.
For critical insights on this market, ask an expert@ https://www.futuremarketinsights.com/ask-question/rep-gb-16236
Competitive Landscape
Some of the leading manufacturers and players assessed in the global pollen allergy market are bioMerieux SA, HOB Biotech Group Corp Ltd, Alcon, HYCOR Biomedical, Inc, Immunomic Therapeutics, Quest Diagnostics Incorporated, Omega Diagnostics Group PLC, Siemens Healthcare Private Limited, Stallergenes Greer, Lincoln Diagnostics, Inc. and others
Manufacturers and players functional in the global pollen allergy market are adopting various corporate growth strategies such as new product launches, mergers and acquisitions, and geographical expansion, among others.
- In July 2022 – Stallergenes Greer, a global healthcare company specialising in allergen immunotherapy (AIT), today announced positive data from its EfficAPSI real-world study. Presented at the 2022 European Academy of Allergy and Clinical Immunology (EAACI) congress in Prague (Czech Republic), the real-world study confirmed significant benefit of sublingual liquid allergen immunotherapy treatment (AIT) on the onset and worsening of asthma in patients with allergic rhinitis.
- Lincoln Diagnostics offers a painless option for skin allergy testing with the Multi-Test PC (pain control). This test still provides high sensitivity, high specificity, and low variability in results but with virtually no pain.
More insights available
The North American region has a significant Pollen Allergies market share due to the high prevalence of allergies, favorable reimbursement policies, and the presence of key market players. The European region also has a substantial market share due to the growing prevalence of allergies, high healthcare spending, and increasing awareness about the available treatment options.
For in-depth competitive analysis, Buy Now@ https://www.futuremarketinsights.com/checkout/16236
Key Segments Covered in the Pollen Allergy Industry Survey
Pollen Allergy Market by Product Type:
- Instruments
- Consumables
- Services
Pollen Allergy Market by Allergen Type:
- Food
- Inhaled
- Drug
- Other
Pollen Allergy Market by Therapeutics Drug class:
- Antihistamines
- Decongestants
- Corticosteroids
- Mast Cell Stabilizers
- Leukotriene Inhibitors
- Nasal Anticholinergics
- Immunomodulators
- Auto injectable Epinephrine
- Immunotherapy
Pollen Allergy Market by End-User:
- Diagnostic Laboratories
- Hospitals
About Future Market Insights, Inc.
Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs
